Pricing for orphan drugs: will the market bear what society cannot?

JAMA. 2013 Oct 2;310(13):1343-4. doi: 10.1001/jama.2013.278129.
No abstract available

MeSH terms

  • Aminophenols / economics
  • Aminophenols / therapeutic use
  • Cost Sharing
  • Cystic Fibrosis / drug therapy
  • Drug Costs*
  • Drug Discovery
  • Drug Industry / economics*
  • Drug Industry / ethics
  • Health Expenditures
  • Humans
  • Orphan Drug Production / economics*
  • Quinolones / economics
  • Quinolones / therapeutic use
  • Social Justice*
  • United States

Substances

  • Aminophenols
  • Quinolones
  • ivacaftor